“During the first quarter, both diagnostics and drug development began experiencing the impact of the global pandemic," CEO Adam Schecter says.
The strain of ransomware that was reportedly used in the attack on LabCorp can "effectively lock down a computer, encrypting all the files inside."
The $1.2 billion acquisition of Chiltern continues a wave of consolidation in the contract research organization industry.
